Recurring HPLC Assay, Purity Testing for Fenbendazole and Ivermectin Capsules

We’re seeking an ISO/IEC 17025:2017 laboratory for recurring HPLC batch-release testing of fenbendazole and ivermectin capsules. Testing is required for fenbendazole 222 mg and 444 mg HPMC capsules and ivermectin 12 mg capsules with MCC filler.

SCOPE (per compound, per lot):

HPLC assay: identity and potency/purity of the active, reported as % label claim and % purity

Chromatogram included on the Certificate of Analysis

Method: lab to confirm whether they have a validated or verified method for each compound (USP/EP monograph or in-house). Please state which.

REQUIREMENTS:

• ISO/IEC 17025:2017 accreditation (A2LA, PJLA/Perry Johnson, ANAB or equivalent) with HPLC in the scope. Please attach your current certificate and scope of accreditation.
• Lot-traceable COA that we can publish and share with customers
• Willing to be named as the testing lab on our COAs

PRICING (please quote):

Flat per-compound HPLC price (our budget is $400 USD or less per compound test)

Any setup, method-verification, or minimum-order fees listed separately

Rush options and the standard turnaround (we need 5–7 business days or better)

LOGISTICS:

Samples ship from South Carolina, USA. Volume is low and irregular, about 3–6 lots per year initially, with potential for growth.

Preference is for simple per-sample pricing without a contract commitment.